Appetite stimulant
Substance that increases appetite
An orexigenic , or appetite stimulant , is a drug , hormone , or compound that increases appetite and may induce hyperphagia . This can be a medication or a naturally occurring neuropeptide hormone, such as ghrelin , orexin or neuropeptide Y ,[ 1] [ 2] which increases hunger and therefore enhances food consumption . Usually appetite enhancement is considered an undesirable side effect of certain drugs as it leads to unwanted weight gain ,[ 3] [ 4] [ 5] but sometimes it can be beneficial and a drug may be prescribed solely for this purpose, especially when the patient is suffering from severe appetite loss or muscle wasting due to cystic fibrosis , anorexia , old age , cancer or AIDS .[ 6] [ 7] [ 8] [ 9] [ 10] There are several widely used drugs which can cause a boost in appetite, including tricyclic antidepressants (TCAs), tetracyclic antidepressants , natural or synthetic cannabinoids , first-generation antihistamines , most antipsychotics and many steroid hormones . In the United States , no hormone or drug has currently been approved by the FDA specifically as an orexigenic, with the exception of Dronabinol , which received approval for HIV/AIDS -induced anorexia only.
List of orexigenics
5-HT2C receptor antagonists /inverse agonists — mirtazapine , olanzapine , quetiapine , amitriptyline , cyproheptadine , lurasidone
H1 receptor antagonists /inverse agonists — mirtazapine , olanzapine , quetiapine , amitriptyline , cyproheptadine , pizotifen
Dopamine antagonists — haloperidol , chlorpromazine , olanzapine , risperidone , quetiapine
Adrenergic antagonists :
Paradoxically, β-adrenergic agonists are also listed.[ 11]
Not ephedra /clenbuterol (which is an appetite suppressant ), but salbutamol , flerobuterol , Zilpaterol , and related drugs.
α2 Adrenergic agonists — clonidine
CB1 receptor agonists (cannabinoids — THC/dronabinol (a component of Cannabis ), nabilone
Corticosteroids — dexamethasone , prednisone , hydrocortisone
Certain pregnene steroids — megestrol acetate , medroxyprogesterone acetate
Anabolic steroids — oxandrolone , boldenone undecylenate , testosterone
Other steroids such as Prednisolone
Sulfonylurea antidiabetic drugs such as glibenclamide , chlorpropamide and tolbutamide
Mood stabilizers such as lithium
Some anti-epileptic drugs such as valproate , carbamazepine and gabapentin [ 12]
α2 δ VDCC ligands — gabapentin , pregabalin [ 13]
Ghrelin receptor agonists such as anamorelin , GHRP-6 , ibutamoren , ipamorelin , and pralmorelin
MC4 receptor antagonists
Insulin
Sugars , such as fructose [ 14]
Alcohol beverages[ 15]
Benzodiazepines , such as diazepam [ 16]
See also
References
^ Diepvens K, Häberer D, Westerterp-Plantenga M (Mar 2008). "Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans". Int J Obes (Lond) . 32 (3): 510–8. doi :10.1038/sj.ijo.0803758 . PMID 18345020 .
^ Akimoto S, Miyasaka K (July 2010). "Age-associated changes of hunger-regulating peptides" . Geriatrics & Gerontology International . 10 Suppl 1: S107–19. doi :10.1111/j.1447-0594.2010.00587.x . PMID 20590826 . S2CID 33227343 .
^ Purnell JQ, Weyer C (2003). "Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity". Treatments in Endocrinology . 2 (1): 33–47. doi :10.2165/00024677-200302010-00004 . PMID 15871553 . S2CID 8088326 .
^ Hermansen K, Mortensen LS (2007). "Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus". Drug Safety . 30 (12): 1127–42. doi :10.2165/00002018-200730120-00005 . PMID 18035865 . S2CID 19877584 .
^ Maayan L, Correll CU (July 2010). "Management of antipsychotic-related weight gain" . Expert Review of Neurotherapeutics . 10 (7): 1175–200. doi :10.1586/ern.10.85 . PMC 3501406 . PMID 20586697 .
^ Strasser F, Bruera ED (June 2002). "Update on anorexia and cachexia". Hematology/Oncology Clinics of North America . 16 (3): 589–617. doi :10.1016/s0889-8588(02)00011-4 . PMID 12170570 .
^ Nasr SZ, Drury D (March 2008). "use in cystic fibrosis" (PDF) . Pediatric Pulmonology . 43 (3): 209–19. doi :10.1002/ppul.20766 . hdl :2027.42/57930 . PMID 18219690 . S2CID 43667706 .
^ Morley JE (2007). "Weight loss in older persons: new therapeutic approaches". Current Pharmaceutical Design . 13 (35): 3637–47. doi :10.2174/138161207782794149 . PMID 18220800 .
^ Fox CB, Treadway AK, Blaszczyk AT, Sleeper RB (April 2009). "Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly". Pharmacotherapy . 29 (4): 383–97. doi :10.1592/phco.29.4.383 . PMID 19323618 . S2CID 6695434 .
^ Holmes S (July 2009). "A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care". International Journal of Palliative Nursing . 15 (7): 320, 322–6. doi :10.12968/ijpn.2009.15.7.43421 . PMID 19648846 .
^ Lang F, Perrier E, Pellet J. [Noradrenergic hypothesis in anorexia nervosa: prospective study using beta-stimulant therapy]. Ann Med Psychol (Paris). 1983;141(8):918-25.
^ Ness-Abramof R, Apovian CM (Aug 2005). "Drug-induced weight gain". Drugs of Today . 41 (8): 547–55. doi :10.1358/dot.2005.41.8.893630 . PMID 16234878 . S2CID 34960274 .
^ LYRICA (pregabalin), CV. Full Prescribing Information, Section 5.7 (Weight Gain). Pfizer, Inc. Revised June, 2013. [1]
^ "Fructose Metabolism: Relation to Food Intake & Metabolic Dysfunction" . themedicalbiochemistrypage.org . Retrieved 14 April 2018 .
^ Caton SJ, Nolan LJ, Hetherington MM (2015). "Alcohol, Appetite and Loss of Restraint". Curr Obes Rep . 4 (1): 99–105. doi :10.1007/s13679-014-0130-y . PMID 26627094 . S2CID 36018101 .
^ Cooper, S. J. (2005). "Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes" . Appetite . 44 (2): 133–150. doi :10.1016/j.appet.2005.01.003 . PMID 15808888 . S2CID 1394424 . Retrieved 14 April 2018 .
Further reading
External links